A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Thomas Jefferson University
ChineseAMS
University of Texas Southwestern Medical Center
Ruijin Hospital
Fudan University